Zhejiang Jingxin Pharmaceutical Co Ltd (Jingxin Pharma) is a manufacturer of Chinese medicine. The company offers products such as finished dosage forms, Chinese herbal drugs and APIs. Its finished dosage products include simvastatin, gliclazide, cisapride and sertraline hydrochloride dispersing tablets, cilnidipine, lovastatin, fenofibrate and ciprofloxacin hydrochloride capsules. Jingxin Pharma’s API products comprise simvastatin, levofloxacin hemihydrate, ciprofloxacin hydrochloride, ofloxacin, levofloxacin lactate, enrofloxacin base, ciprofloxacin lactate, enrofloxacin hydrochloride and rosuvastatin calcium among others. The company’s Chinese herbal drugs include coptis bolus,mind-easing tonic, leucorrhea pill, sexton pill, menstruation-regulating bolus and bolus for indigestion among others. It offers its products in the dosage forms of capsules, tablets, large-volume injections and powder for injections. Jingxin Pharma is headquartered in Xinchang, Zhejiang, China.
Zhejiang Jingxin Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
Products |
---|
Drugs: |
Consistency Evaluation Products |
Cardiovascular System Drugs |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Zhejiang Jingxin Pharmaceutical Co Ltd | Humanwell Healthcare Group Co Ltd | Zhangzhou Pien Tze Huang Pharmaceutical Co Ltd | Shandong Xinhua Pharmaceutical Co Ltd | Yifan Pharmaceutical Co Ltd |
---|---|---|---|---|---|
Headquarters | China | China | China | China | China |
City | Shaoxing | Wuhan | Zhangzhou | Zibo | Hangzhou |
State/Province | Zhejiang | Hubei | Fujian | Shandong | Zhejiang |
No. of Employees | 3,909 | 17,676 | 2,720 | 7,104 | 4,338 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Lu Gang | Chairman | Executive Board | 2004 | 61 |
Wang Nengneng | Vice Chairman | Executive Board | 2010 | 49 |
Chen Meili | Director; Vice President; Chief Financial Officer | Executive Board | 2019 | 53 |
Jin Zhiping | President; Director | Executive Board | 2019 | 42 |
Hong Yunfei | Secretary; Director | Executive Board | 2019 | 42 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward